Cargando…
Utilisation des bactéries lactiques comme vecteurs vaccinaux
Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to pro...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270964/ https://www.ncbi.nlm.nih.gov/pubmed/32518601 http://dx.doi.org/10.1016/S1773-035X(09)70312-0 |
_version_ | 1783541997386072064 |
---|---|
author | Bermúdez-Humarán, Luis G. Langella, Philippe |
author_facet | Bermúdez-Humarán, Luis G. Langella, Philippe |
author_sort | Bermúdez-Humarán, Luis G. |
collection | PubMed |
description | Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to produce fermented foods. They are thus good candidates to develop novel oral vectors and constitute attractive alternatives to vaccinal strategies based on attenuated pathogens which could induce healthy risks. Here, we summarized the most recent researches performed on the use of LAB as live vaccine delivery vectors. |
format | Online Article Text |
id | pubmed-7270964 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72709642020-06-05 Utilisation des bactéries lactiques comme vecteurs vaccinaux Bermúdez-Humarán, Luis G. Langella, Philippe Rev Francoph Lab Article Today, sufficient consistent data are available to reinforce the interest of the use of Lactic Acic Bacteria (LAB), particularly lactococci and lactobacilli strains, to develop novel mucosal vaccination strategies. LAB are Gram positive bacteria exploited since the highest Antiquity by humans to produce fermented foods. They are thus good candidates to develop novel oral vectors and constitute attractive alternatives to vaccinal strategies based on attenuated pathogens which could induce healthy risks. Here, we summarized the most recent researches performed on the use of LAB as live vaccine delivery vectors. Elsevier Masson SAS. 2009-12 2009-12-11 /pmc/articles/PMC7270964/ /pubmed/32518601 http://dx.doi.org/10.1016/S1773-035X(09)70312-0 Text en Copyright © 2009 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bermúdez-Humarán, Luis G. Langella, Philippe Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title | Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title_full | Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title_fullStr | Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title_full_unstemmed | Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title_short | Utilisation des bactéries lactiques comme vecteurs vaccinaux |
title_sort | utilisation des bactéries lactiques comme vecteurs vaccinaux |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270964/ https://www.ncbi.nlm.nih.gov/pubmed/32518601 http://dx.doi.org/10.1016/S1773-035X(09)70312-0 |
work_keys_str_mv | AT bermudezhumaranluisg utilisationdesbacterieslactiquescommevecteursvaccinaux AT langellaphilippe utilisationdesbacterieslactiquescommevecteursvaccinaux |